WHO/AFRO. The health of the people: what works – the African Regional Health Report. Public health - organization and administration. 2014.
Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN. Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med. 2011;41(6 Suppl 4):S398–405.
Article
PubMed
PubMed Central
Google Scholar
Steinberg MH. Genetic etiologies for phenotypic diversity in sickle cell anemia. ScientificWorldJournal. 2009;9:46–67.
Article
PubMed
Google Scholar
Rees DC, Gibson JS. Biomarkers in sickle cell disease. Br J Haematol. 2012;156(4):433–45.
Article
CAS
PubMed
Google Scholar
Steinberg MH, Coleman MB, Adams JG, Rosenstock W. Interaction between HBS-beta-o-thalassemia and alpha-thalassemia. Am J Med Sci. 1984;288(5):195–9.
Article
CAS
PubMed
Google Scholar
Steinberg MH, Sebastiani P. Genetic modifiers of sickle cell disease. Am J Hematol. 2012;87(8):795–803.
Article
CAS
PubMed
PubMed Central
Google Scholar
Adorno EV, Couto FD, Moura Neto JP, Menezes JF, Rego M, Reis MG, et al. Hemoglobinopathies in newborns from Salvador, Bahia, Northeast Brazil. Cadernos de saude publica. 2005;21(1):292–8.
Article
PubMed
Google Scholar
Charache S. Fetal hemoglobin, sickling, and sickle cell disease. Adv Pediatr. 1990;37:1–31.
CAS
PubMed
Google Scholar
Nagel RL, Fabry ME. Sickle cell anemia as a multigenetic disease: new insights into the mechanism of painful crisis. Prog Clin Biol Res. 1984;165:93–102.
CAS
PubMed
Google Scholar
Goncalves MS, Bomfim GC, Maciel E, Cerqueira I, Lyra I, Zanette A, et al. BetaS-haplotypes in sickle cell anemia patients from Salvador, Bahia, Northeastern Brazil. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica [et al]. 2003;36(10):1283–8.
Steinberg MH. Predicting clinical severity in sickle cell anaemia. Br J Haematol. 2005;129(4):465–81.
Article
CAS
PubMed
Google Scholar
Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21(1):37–47.
Article
PubMed
Google Scholar
Damanhouri GA, Jarullah J, Marouf S, Hindawi SI, Mushtaq G, Kamal MA. Clinical biomarkers in sickle cell disease. Saudi journal of biological sciences. 2015;22(1):24–31.
Article
CAS
PubMed
Google Scholar
Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA. 2003;289(13):1645–51.
Article
CAS
PubMed
Google Scholar
Raphael JL, Dietrich CL, Whitmire D, Mahoney DH, Mueller BU, Giardino AP. Healthcare utilization and expenditures for low income children with sickle cell disease. Pediatr Blood Cancer. 2009;52(2):263–7.
Article
PubMed
Google Scholar
Pizzo E, Laverty AA, Phekoo KJ, AlJuburi G, Green SA, Bell D, et al. A retrospective analysis of the cost of hospitalizations for sickle cell disease with crisis in England, 2010/11. J Public Health (Oxf). 2015;37(3):529–39.
Article
CAS
Google Scholar
Nims RW, Cook JC, Krishna MC, Christodoulou D, Poore CM, Miles AM, et al. Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. Methods Enzymol. 1996;268:93–105.
Article
CAS
PubMed
Google Scholar
Sutton M, Bouhassira EE, Nagel RL. Polymerase chain reaction amplification applied to the determination of beta-like globin gene cluster haplotypes. Am J Hematol. 1989;32(1):66–9.
Article
CAS
PubMed
Google Scholar
Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood. 2000;95(1):360–2.
CAS
PubMed
Google Scholar
Carroll PC, Haywood C Jr, Hoot MR, Lanzkron S. A preliminary study of psychiatric, familial, and medical characteristics of high-utilizing sickle cell disease patients. Clin J Pain. 2013;29(4):317–23.
Article
PubMed
PubMed Central
Google Scholar
Loureiro MM, Rozenfeld S. Epidemiology of sickle cell disease hospital admissions in Brazil. Rev Saude Publica. 2005;39(6):943–9.
Article
PubMed
Google Scholar
Adegoke SA, Adeodu OO, Adekile AD. Sickle cell disease clinical phenotypes in children from south-western. Nigeria Niger J Clin Pract. 2015;18(1):95–101.
CAS
PubMed
Google Scholar
Ballas SK, Kesen MR, Goldberg MF, Lutty GA, Dampier C, Osunkwo I, et al. Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. ScientificWorldJournal. 2012;2012:949535.
Article
PubMed
PubMed Central
Google Scholar
Serjeant GR. Screening for sickle-cell disease in Brazil. Lancet (London, England). 2000;356(9224):168–9.
Aleluia MM, Santiago RP, da Guarda CC, Fonseca TCC, Neves FI, Quinto RS, et al. Genetic Modulation of Fetal Hemoglobin in Hydroxyurea-Treated Sickle Cell Anemia. American journal of hematology. 2017:n/a-n/a.
Verger. Flux et Reflux de la Traite des Nègres Entre le Golfe de Benin et Bahia de Todos os Santos. Mouton Press, Paris, France. 1968.
Florentino M. Em Costas Negras. Companhia das Letras Press. 1997.
Google Scholar
Powars DR. Beta s-gene-cluster haplotypes in sickle cell anemia. Clinical and hematologic features. Hematol Oncol Clin North Am. 1991;5(3):475–93.
CAS
PubMed
Google Scholar
Harteveld CL, Higgs DR. Alpha-thalassaemia. Orphanet journal of rare diseases. 2010;5:13.
Article
PubMed
PubMed Central
Google Scholar
Figueiredo MS, Kerbauy J, Goncalves MS, Arruda VR, Saad ST, Sonati MF, et al. Effect of alpha-thalassemia and beta-globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia in Brazil. Am J Hematol. 1996;53(2):72–6.
Article
CAS
PubMed
Google Scholar
Lyra IM, Goncalves MS, Braga JA, Gesteira Mde F, Carvalho MH, Saad ST, et al. Clinical, hematological, and molecular characterization of sickle cell anemia pediatric patients from two different cities in Brazil. Cadernos de saude publica. 2005;21(4):1287–90.
Article
PubMed
Google Scholar
Kato GJ, Hebbel RP, Steinberg MH, Gladwin MT. Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol. 2009;84(9):618–25.
Article
CAS
PubMed
PubMed Central
Google Scholar
Discher DE, Ney PA. The reason sickle reticulocytes expose PS. Blood. 2015;126(15):1737–8.
Article
PubMed
Google Scholar
Belanger AM, Keggi C, Kanias T, Gladwin MT, Kim-Shapiro DB. Effects of nitric oxide and its congeners on sickle red blood cell deformability. Transfusion. 2015;55(10):2464–72.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vilas-Boas W, Cerqueira BA, Zanette AM, Reis MG, Barral-Netto M, Goncalves MS. Arginase levels and their association with Th17-related cytokines, soluble adhesion molecules (sICAM-1 and sVCAM-1) and hemolysis markers among steady-state sickle cell anemia patients. Ann Hematol. 2010;89(9):877–82.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dutra FF, Alves LS, Rodrigues D, Fernandez PL, de Oliveira RB, Golenbock DT, et al. Hemolysis-induced lethality involves inflammasome activation by heme. Proc Natl Acad Sci U S A. 2014;111(39):E4110–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Colella MP, de Paula EV, Machado-Neto JA, Conran N, Annichino-Bizzacchi JM, Costa FF, et al. Elevated hypercoagulability markers in hemoglobin SC disease. Haematologica. 2015;100(4):466–71.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wun T, Paglieroni T, Tablin F, Welborn J, Nelson K, Cheung A. Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia. J Lab Clin Med. 1997;129(5):507–16.
Article
CAS
PubMed
Google Scholar
Villagra J, Shiva S, Hunter LA, Machado RF, Gladwin MT, Kato GJ. Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood. 2007;110(6):2166–72.
Article
CAS
PubMed
PubMed Central
Google Scholar
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama. 2001;285(19):2486–97.
Movva R, Rader DJ. Laboratory assessment of HDL heterogeneity and function. Clin Chem. 2008;54(5):788–800.
Article
CAS
PubMed
Google Scholar
Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986;314(25):1593–9.
Article
CAS
PubMed
Google Scholar
Dixit R, Nettem S, Madan SS, Soe HH, Abas AB, Vance LD, et al. Folate supplementation in people with sickle cell disease. Cochrane Database Syst Rev. 2016;2:Cd011130.
Martyres DJ, Vijenthira A, Barrowman N, Harris-Janz S, Chretien C, Klaassen RJ. Nutrient insufficiencies/deficiencies in children with sickle cell disease and its association with increased disease severity. Pediatr Blood Cancer. 2016;
Nwenyi E, Leafman J, Mathieson K, Ezeobah N. Differences in quality of life between pediatric sickle cell patients who used hydroxyurea and those who did not. Int J Health Care Qual Assur. 2014;27(6):468–81.
Article
PubMed
Google Scholar